Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: The last therapeutic challenge

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 10, 2012, Pages 1234-1237

  Piano, Salvatore ^a   Romano, Antonietta ^a   Rosi, Silvia ^a   Gatta, Angelo ^a   Angeli, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

ascites; carbapenemase producer Klebsiella pneumoniae; enterobacteriaceae; liver transplantation; nosocomial infection; spontaneous bacterial peritonitis

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; COLISTIN; DAPTOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; TIGECYCLINE;

ABDOMINAL PAIN; ADULT; AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BACTERIUM ISOLATION; CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE INFECTION; CASE REPORT; FEVER; HEPATIC ENCEPHALOPATHY; HUMAN; KIDNEY FAILURE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NEUTROPHIL COUNT; NOSE SMEAR; PARACENTESIS; PATIENT MONITORING; PERITONEAL FLUID; PRIORITY JOURNAL; RESPIRATORY DISTRESS;

BETA-LACTAM RESISTANCE; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FATTY LIVER; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PERITONITIS;

EID: 84866317126     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328355d8a2     Document Type: Article

References (22)

1. Buré A, Legrand P, Arlet G, Jarlier V, Paul G, Philippon A. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis 1988; 7:780-782. (Pubitemid 19017165)
2. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant entero-bacteriaceae: epidemiology and prevention. Clin Infect Dis 2011; 53:60-67.
3. Ariza X, Castellote J, Lora-Tamayo J, Girbau A, Salord S, Rota R, et al. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol 2012; 56:825-832.
4. Ginès P, Angeli P, Lenz K, Møller S, Moore K, Moreau R, et al.; European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53:397-417.
5. Fernández J, Acevedo J, Castro M, Garcia O, Rodŕiguez de Lope C, Roca D, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012; 55:1551-1561.
6. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35:140-148. (Pubitemid 34032554)
7. Piano S, Morando F, Fasolato S, Cavallin M, Boscato N, Boccagni P, et al. Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation? J Hepatol 2011; 55:491-496.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. Document M100-S17. Wayne, PA: CLSI; 2007.
9. Lomaestro BM, Tobin EH, Shang W, Gootz T. The Spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York. Clin Infect Dis 2006; 43:e26-e28.
10. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-317. (Pubitemid 39050477)
11. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45:1151-1161. (Pubitemid 32230996)
12. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29:1099-1106.
13. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52:1028-1033. (Pubitemid 351358384)
14. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010; 65: 1119-1125.
15. Hampel H, Bynum GD, Zamora E, El-Serag HB. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol 2001; 96:2206-2210. (Pubitemid 32660919)
16. Pogue JM, Lee J, Marchaim D, Yee V, Zhao JJ, Chopra T, et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis 2011; 53:879-884.
17. Yahav D, Lador A, Paul M, Leibovici L. Efficacy and safety of tigecycline: a systematic review and meta-analysis. J Antimicrob Chemother 2011; 66:1963-1971.
18. Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009; 37:8540-8551.
19. Saidel-Odes L, Polachek H, Peled N, Riesenberg K, Schlaeffer F, Trabelsi Y, et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol 2012; 33:14-19.
20. Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K. pneumoniae. Am J Infect Control 2012; 40: 421-425.
21. Bergamasco MD, Barroso Barbosa M, de Oliveira Garcia D, Cipullo R, Moreira JC, Baia C, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Transpl Infect Dis 2012; 14:198-205.
22. Ciobotaro P, Oved M, Nadir E, Bardenstein R, Zimhony O. An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice. Am J Infect Control 2011; 39:671-677.